Research Options: Select below IPO Calendar	Week of Expected Pricing Pending Company Name PROLUNG INC Proposed Ticker LUNG CUSIP 74348P209 Business Description A medical technology company specializing in predictive analytic, early stage lung cancer risk testing, which we refer to as the “ProLung Test.” Lead Underwriter Aegis Capital Corp. ,Maxim Group, LLC Co-Managers N/A Initial Shares 7,000,000 Revised Initial Shares 933,334 Initial Price $7.00-$8.00 Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.